title: Iron overload in African Americans.
abstract: OBJECTIVE
  Iron overload unexplained by dietary or medicinal iron excess, transfusion, or sideroblastic anemia has been described infrequently in Americans of African descent. The purpose of this study was to characterize iron overload attributable to excessive iron absorption in African Americans.
  
  
  METHODS
  In a community hematology and medical oncology practice during the interval 1990 to 1993, we identified and evaluated a series of cases comprised of 6 men and 1 woman, with a mean age of 55 +/- 14 (SD) years (range 33 to 69). Data on clinical features, serum iron parameters, liver and body iron stores, evaluations of anemia, human leukocyte antigen (HLA) typing, and family studies were analyzed.
  
  
  RESULTS
  Among our patients, the serum iron parameters were: iron concentration 26 +/- 13 mumol/L, transferrin saturation 59 +/- 21%, and ferritin concentration 1,588 +/- 1,053 micrograms/L. Clinical abnormalities observed included weakness and fatigue, decreased libido and impotence, hepatopathy, arthropathy, diabetes mellitus, hypogonadotrophic hypogonadism, and hyperpigmentation. Hepatic parenchymal cell iron deposits were increased in each of the 6 patients studied, and Kupffer cell iron deposits were prominent in 4. The occurrence of iron overload was verified by liver iron quantification and therapeutic phlebotomy. Four subjects had alpha-thalassemia minor; 2 others had hemoglobin S and C traits. No proband had HLA-A3 positivity. Four probands had other family members with iron overload.
  
  
  CONCLUSIONS
  In comparison with Caucasians with hemochromatosis, our patients have slightly lower mean values of serum iron concentration and transferrin saturation, more Kupffer cell iron deposits, a higher incidence of thalassemia and hemoglobinopathy, and infrequent positivity for HLA-A3. Iron overload in African Americans appears to be more similar to that in certain sub-Saharan African natives than to hemochromatosis.
authors.affiliation: Brookwood Medical Center, Birmingham, Alabama 35209, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Barton
authors.forename: C Q
authors.initials: CQ
authors.lastname: Edwards
authors.forename: L F
authors.initials: LF
authors.lastname: Bertoli
authors.forename: T W
authors.initials: TW
authors.lastname: Shroyer
authors.forename: S L
authors.initials: SL
authors.lastname: Hudson
mesh_terms: D000328:Adult; D000368:Aged; D044383:Black People; D005260:Female; D006680:HLA Antigens / Q000097:blood; D006486:Hemosiderosis / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D006801:Humans; D016130:Immunophenotyping; D007501:Iron / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D001741:Black or African American
chemical_list: D006680:HLA Antigens; D007501:Iron